Articles de revues sur le sujet « Silymarin/ Silibinin »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 50 meilleurs articles de revues pour votre recherche sur le sujet « Silymarin/ Silibinin ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Jiang, Hui-Hui, Fa-Shun Yan, Liang Shen, and Hong-Fang Ji. "Silymarin versus Silibinin: Differential Antioxidant and Neuroprotective Effects against H2O2-induced Oxidative Stress in PC12 Cells." Natural Product Communications 11, no. 5 (2016): 1934578X1601100. http://dx.doi.org/10.1177/1934578x1601100520.
Texte intégralRakelly de Oliveira, Dayanne, Saulo Relison Tintino, Maria Flaviana Bezerra Morais Braga, et al. "In VitroAntimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin." BioMed Research International 2015 (2015): 1–7. http://dx.doi.org/10.1155/2015/292797.
Texte intégralKang, Min Kyung, Soo Kyung Bae, Jin Wan Kim, and Myung Gull Lee. "Pharmacokinetic Interaction Between Oltipraz and Silymarin in Rats." Journal of Pharmacy & Pharmaceutical Sciences 12, no. 1 (2009): 1. http://dx.doi.org/10.18433/j38c7w.
Texte intégralDuan, Wentao, Zexian Ou, Yuxing Huang, et al. "Silibinin Inhibits Cell Ferroptosis and Ferroptosis-Related Tissue Injuries." Antioxidants 12, no. 12 (2023): 2119. http://dx.doi.org/10.3390/antiox12122119.
Texte intégralKadoglou, Nikolaos P. E., Chrystalla Panayiotou, Michail Vardas, et al. "A Comprehensive Review of the Cardiovascular Protective Properties of Silibinin/Silymarin: A New Kid on the Block." Pharmaceuticals 15, no. 5 (2022): 538. http://dx.doi.org/10.3390/ph15050538.
Texte intégralMilić, Nataša, Nataša Milošević, Ljiljana Suvajdžić, Marija Žarkov, and Ludovico Abenavoli. "New Therapeutic Potentials of Milk Thistle (Silybum marianum)." Natural Product Communications 8, no. 12 (2013): 1934578X1300801. http://dx.doi.org/10.1177/1934578x1300801236.
Texte intégralAKBEL, Erten, İbrahim BULDUK, and Funda KARABAĞ. "Developing Rp-Hplc Method and Determination in Vitro Cytotoxicity of Silymarin Obtained From Silybum marinum Plant." MAS Journal of Applied Sciences 9, Special Issue (2024): 899–906. https://doi.org/10.5281/zenodo.13939065.
Texte intégralShiri, Sabah, Naser Abbasi, Kamal Alizadeh, and Elahe Karimi. "Novel and green synthesis of a nanopolymer and its use as a drug delivery system of silibinin and silymarin extracts in the olfactory ensheathing cells of rats in normal and high-glucose conditions." RSC Advances 9, no. 67 (2019): 38912–27. http://dx.doi.org/10.1039/c9ra05608d.
Texte intégralVerdura, Sara, Elisabet Cuyàs, Verónica Ruiz-Torres, et al. "Lung Cancer Management with Silibinin: A Historical and Translational Perspective." Pharmaceuticals 14, no. 6 (2021): 559. http://dx.doi.org/10.3390/ph14060559.
Texte intégralAhmadi, Yasin, Mohammad Mehdi Mahboobian, and Mojdeh Mohammadi. "Silibinin and Nano-silibinin in Cuprizone Model of Multiple Sclerosis: Behavioral and Biochemical Investigation." Current Drug Therapy 16, no. 5 (2021): 439–47. http://dx.doi.org/10.2174/1574885517666211216161317.
Texte intégralYang, Zongguo, Liping Zhuang, Yunfei Lu, Qingnian Xu, and Xiaorong Chen. "Effects and Tolerance of Silymarin (Milk Thistle) in Chronic Hepatitis C Virus Infection Patients: A Meta-Analysis of Randomized Controlled Trials." BioMed Research International 2014 (2014): 1–9. http://dx.doi.org/10.1155/2014/941085.
Texte intégralKhobzei, K. M., and V. M. Bilonoh. "Psoriasis and metabolically associated liver disease. Justification of hepatotropic therapy in complex therapy of patients with psoriasis." Ukrainian Journal of Dermatology, Venerology, Cosmetology, no. 3 (September 30, 2023): 25–35. http://dx.doi.org/10.30978/ujdvk2023-3-25.
Texte intégralLim, Je-Oh, Na-Rae Shin, Yun-Soo Seo, et al. "Silibinin Attenuates Silica Dioxide Nanoparticles-Induced Inflammation by Suppressing TXNIP/MAPKs/AP-1 Signaling." Cells 9, no. 3 (2020): 678. http://dx.doi.org/10.3390/cells9030678.
Texte intégralEsselun, Carsten, Bastian Bruns, Stephanie Hagl, Rekha Grewal, and Gunter P. Eckert. "Differential Effects of Silibinin A on Mitochondrial Function in Neuronal PC12 and HepG2 Liver Cells." Oxidative Medicine and Cellular Longevity 2019 (November 23, 2019): 1–10. http://dx.doi.org/10.1155/2019/1652609.
Texte intégralPriyanka Sudhakar Somkuwar, Isha Rajesh Singh, and Achal Dilip Rahate. "Milk thistle as liver cleanser." World Journal of Biology Pharmacy and Health Sciences 20, no. 2 (2024): 063–70. http://dx.doi.org/10.30574/wjbphs.2024.20.2.0812.
Texte intégralKoltai, Tomas, and Larry Fliegel. "Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions." Journal of Evidence-Based Integrative Medicine 27 (January 2022): 2515690X2110688. http://dx.doi.org/10.1177/2515690x211068826.
Texte intégralKim, Jung-Lye, Yun-Ho Kim, Min-Kyung Kang, Ju-Hyun Gong, Seoung-Jun Han, and Young-Hee Kang. "Antiosteoclastic Activity of Milk Thistle Extract after Ovariectomy to Suppress Estrogen Deficiency-Induced Osteoporosis." BioMed Research International 2013 (2013): 1–11. http://dx.doi.org/10.1155/2013/919374.
Texte intégralJyoti, Thakur*. "An Overview on Pharmacological Activities of Silybum Marianum (Milk Thistle)." International Journal of Pharmaceutical Sciences 3, no. 5 (2025): 1820–28. https://doi.org/10.5281/zenodo.15385799.
Texte intégralFitzpatrick, Leo, Ella Mokrushin, George Talbott, and Tibebe Woldermariam. "In Vitro and Ex Vivo Effects of Silymarin Derivatives on Proinflammatory Cytokine Secretion Using a Murine Colonic Strip Model." Planta Medica International Open 5, no. 02 (2018): e55-e60. http://dx.doi.org/10.1055/a-0733-3716.
Texte intégralKatiyar, Santosh K., Anshu M. Roy, and Manjeshwar S. Baliga. "Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation." Molecular Cancer Therapeutics 4, no. 2 (2005): 207–16. http://dx.doi.org/10.1158/1535-7163.207.4.2.
Texte intégralGorhe, Ankita Arun, Abhijeet Kulkarni, Kandalkar Pallavi, and Jagtap Snehal. "Silymarin Loaded Novel Drug Delivery for Oral and Topical Administration." Journal of Drug Delivery and Therapeutics 10, no. 3-s (2020): 262–70. http://dx.doi.org/10.22270/jddt.v10i3-s.4125.
Texte intégralAshrafizadeh, Milad, Zahra Ahmadi, Reza Mohammadinejad, Tahereh Farkhondeh, and Saeed Samarghandian. "Nano-soldiers Ameliorate Silibinin Delivery: A Review Study." Current Drug Delivery 17, no. 1 (2020): 15–22. http://dx.doi.org/10.2174/1567201816666191112113031.
Texte intégralQadir, Abdul, and PK Sahoo. "Silymarin: An account of Phytochemistry and Pharmacology." Journal of Phytopharmacology 10, no. 4 (2021): 262–65. http://dx.doi.org/10.31254/phyto.2021.10408.
Texte intégralZhang, Xiang, Zhenghao Jiang, Xiaoliang Jin, and Qiujun Zhou. "Efficacy of traditional Chinese medicine combined with Silibinin on nonalcoholic fatty liver disease: A meta-analysis and systematic review." Medicine 103, no. 5 (2024): e37052. http://dx.doi.org/10.1097/md.0000000000037052.
Texte intégralArghidash, Faezeh, Fatemeh Gheybi, Hamid Gholamhosseinian, Prashant Kesharwani, and Amirhossein Sahebkar. "Radioprotective and radiosensitizing properties of silymarin/silibinin in response to ionizing radiation." Pathology - Research and Practice 270 (June 2025): 156002. https://doi.org/10.1016/j.prp.2025.156002.
Texte intégralStoiljkovic, Zora, Slobodan Petrovic, and Biljana Ilic. "Examination of localization of silymarin and fatty oil in Silybum marianum (L.) Gaertn. fruit." Chemical Industry and Chemical Engineering Quarterly 13, no. 2 (2007): 55–59. http://dx.doi.org/10.2298/ciceq0702055s.
Texte intégralOrhan, Ilkay, Murat Kartal, Fatma Tosun, and Bilge Şener. "Screening of Various Phenolic Acids and Flavonoid Derivatives for their Anticholinesterase Potential." Zeitschrift für Naturforschung C 62, no. 11-12 (2007): 829–32. http://dx.doi.org/10.1515/znc-2007-11-1210.
Texte intégralDeep, G., R. P. Singh, C. Agarwal, D. J. Kroll, and R. Agarwal. "Silymarin and silibinin cause G1 and G2–M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin." Oncogene 25, no. 7 (2005): 1053–69. http://dx.doi.org/10.1038/sj.onc.1209146.
Texte intégralD'Andrea, Vanesa, Leonardo M. Pérez, and Enrique J. Sánchez Pozzi. "Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide." Life Sciences 77, no. 6 (2005): 683–92. http://dx.doi.org/10.1016/j.lfs.2005.01.011.
Texte intégralFernandes Veloso Borges, Flávio, Carolina Ribeiro e Silva, Wanessa Moreira Goes, et al. "Protective Effects of Silymarin and Silibinin against DNA Damage in Human Blood Cells." BioMed Research International 2018 (October 2, 2018): 1–8. http://dx.doi.org/10.1155/2018/6056948.
Texte intégralSurai, Peter F., Anton Surai, and Katie Earle-Payne. "Silymarin and Inflammation: Food for Thoughts." Antioxidants 13, no. 1 (2024): 98. http://dx.doi.org/10.3390/antiox13010098.
Texte intégralGioti, Katerina, Anastasia Papachristodoulou, Dimitra Benaki, et al. "Silymarin Enriched Extract (Silybum marianum) Additive Effect on Doxorubicin-Mediated Cytotoxicity in PC-3 Prostate Cancer Cells." Planta Medica 85, no. 11/12 (2019): 997–1007. http://dx.doi.org/10.1055/a-0954-6704.
Texte intégralChang, Jen-Chih, Yu-Tse Wu, Wen-Chuan Lee, Lie-Chwen Lin, and Tung-Hu Tsai. "Herb–drug interaction of silymarin or silibinin on the pharmacokinetics of trazodone in rats." Chemico-Biological Interactions 182, no. 2-3 (2009): 227–32. http://dx.doi.org/10.1016/j.cbi.2009.09.005.
Texte intégralRomanucci, Valeria, Rita Pagano, Antonio Lembo, et al. "Phosphodiester Silybin Dimers Powerful Radical Scavengers: A Antiproliferative Activity on Different Cancer Cell Lines." Molecules 27, no. 5 (2022): 1702. http://dx.doi.org/10.3390/molecules27051702.
Texte intégralŠimánek, V., N. Škottová, J. Bartek, et al. "Extract from Silybum marianum as a nutraceutical: a double-blind placebo-controlled study in healthy young men." Czech Journal of Food Sciences 19, No. 3 (2013): 106–10. http://dx.doi.org/10.17221/6585-cjfs.
Texte intégralYamasaki, Keishi, Hiroki Sato, Saori Minagoshi, et al. "The Binding of Silibinin, the Main Constituent of Silymarin, to Site I on Human Serum Albumin." Biological & Pharmaceutical Bulletin 40, no. 3 (2017): 310–17. http://dx.doi.org/10.1248/bpb.b16-00790.
Texte intégralShen, Liang, Lu Liu, Xin-Yu Li, and Hong-Fang Ji. "Regulation of gut microbiota in Alzheimer’s disease mice by silibinin and silymarin and their pharmacological implications." Applied Microbiology and Biotechnology 103, no. 17 (2019): 7141–49. http://dx.doi.org/10.1007/s00253-019-09950-5.
Texte intégralBasiglio, Cecilia L., Enrique J. Sánchez Pozzi, Aldo D. Mottino, and Marcelo G. Roma. "Differential effects of silymarin and its active component silibinin on plasma membrane stability and hepatocellular lysis." Chemico-Biological Interactions 179, no. 2-3 (2009): 297–303. http://dx.doi.org/10.1016/j.cbi.2008.12.008.
Texte intégralDeep, Gagan, Komal Raina, Rana P. Singh, Nicholas H. Oberlies, David J. Kroll, and Rajesh Agarwal. "Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: Comparison with silymarin and silibinin." International Journal of Cancer 123, no. 12 (2008): 2750–58. http://dx.doi.org/10.1002/ijc.23879.
Texte intégralHorablaga, Adina, Alina Şibu (Ciobanu), Corina Iuliana Megyesi та ін. "Estimation of the Controlled Release of Antioxidants from β-Cyclodextrin/Chamomile (Matricaria chamomilla L.) or Milk Thistle (Silybum marianum L.), Asteraceae, Hydrophilic Extract Complexes through the Fast and Cheap Spectrophotometric Technique". Plants 12, № 12 (2023): 2352. http://dx.doi.org/10.3390/plants12122352.
Texte intégralPár, Alajos, Erzsébet Rőth, Attila Miseta, et al. "Effects of silymarin supplementation in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study." Orvosi Hetilap 150, no. 2 (2009): 73–79. http://dx.doi.org/10.1556/oh.2009.28517.
Texte intégralEzhilarasan, Devaraj, and Thangavelu Lakshmi. "A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases." Oxidative Medicine and Cellular Longevity 2022 (May 11, 2022): 1–15. http://dx.doi.org/10.1155/2022/9233650.
Texte intégralTäger, Michael, Jörn Dietzmann, Ute Thiel, Klaus Hinrich Neumann, and Siegfried Ansorge. "Restoration of the cellular thiol status of peritoneal macrophages from CAPD patients by the flavonoids silibinin and silymarin." Free Radical Research 34, no. 2 (2001): 137–51. http://dx.doi.org/10.1080/10715760100300131.
Texte intégralChevaliez, S., A. Ahmed-Belkacem, A. Soulier, et al. "744 IN VIVO AND IN VITRO RESISTANCE TO SILIBININ, A COMPONENT OF SILYMARIN AND POTENT INHIBITOR OF HCV REPLICATION." Journal of Hepatology 52 (April 2010): S289—S290. http://dx.doi.org/10.1016/s0168-8278(10)60746-5.
Texte intégralBinienda, Agata, Sylwia Ziolkowska, and Elzbieta Pluciennik. "The Anticancer Properties of Silibinin: Its Molecular Mechanism and Therapeutic Effect in Breast Cancer." Anti-Cancer Agents in Medicinal Chemistry 20, no. 15 (2020): 1787–96. http://dx.doi.org/10.2174/1871520620666191220142741.
Texte intégralRad, Z. Mahmoudi, H. Nourafcan, N. Mohebalipour, A. Assadi, and S. Jamshidi. "EFFECT OF SALICYLLC ACID FOLIAR APPLICATION ON PHYTOCHEMICAL COMPOSITION, ANTIOXIDANT AND ANTIMICROBIAL ACTIVITY OF SILYBUM MARIANUM." IRAQI JOURNAL OF AGRICULTURAL SCIENCES 52, no. 1 (2021): 63–69. http://dx.doi.org/10.36103/ijas.v52i1.1236.
Texte intégralBhatia, Neehar, Jifu Zhao, Douglas M. Wolf, and Rajesh Agarwal. "Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin." Cancer Letters 147, no. 1-2 (1999): 77–84. http://dx.doi.org/10.1016/s0304-3835(99)00276-1.
Texte intégralYassin, Nour Y. S., Sameh F. AbouZid, Asmaa M. El-Kalaawy, Tarek M. Ali, Basem H. Elesawy та Osama M. Ahmed. "Tackling of Renal Carcinogenesis in Wistar Rats by Silybum marianum Total Extract, Silymarin, and Silibinin via Modulation of Oxidative Stress, Apoptosis, Nrf2, PPARγ, NF-κB, and PI3K/Akt Signaling Pathways". Oxidative Medicine and Cellular Longevity 2021 (30 вересня 2021): 1–19. http://dx.doi.org/10.1155/2021/7665169.
Texte intégralTyagi, A., K. Raina, R. P. Singh, et al. "Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice." Molecular Cancer Therapeutics 6, no. 12 (2007): 3248–55. http://dx.doi.org/10.1158/1535-7163.mct-07-2006.
Texte intégralEsselun, Carsten, Bastian Bruns, Stephanie Hagl, Rekha Grewal, and Gunter P. Eckert. "Impact of Silibinin A on Bioenergetics in PC12APPsw Cells and Mitochondrial Membrane Properties in Murine Brain Mitochondria." Antioxidants 10, no. 10 (2021): 1520. http://dx.doi.org/10.3390/antiox10101520.
Texte intégral